Found 10 matching trials
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma
PHASE3The purpose of this study is to evaluate the safety and efficacy of orelabr...
Location
The first affiliated hospital of bengbu medical college
Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL
PHASE2This study is a multi-center, open-label, single-arm, non-randomized phase ...
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
PHASE1The purpose of the study is to assess the Safety, Tolerability, PK/PD and p...
Location
The First Affiliated Hospital of Bengbu Medical College
Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
N/ATo evaluate the safety and effecacy of Orelabrutinib therapy in patients wi...
Location
Deparment of Hematology, Peking University People's Hospital
A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies
PHASE1This is a Phase I/II, multicenter, open-label study to evaluate the safety,...
Status
Active Not Recruiting
Location
Mayo Clinic-Mayo Clinic Hospital-Phoenix
Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma
PHASE2This is a phase II, prospective clinical study to evaluate the efficacy and...
Status
Active Not Recruiting
Location
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement
PHASE2This single-center, open, single-arm study aim to evaluate the efficacy and...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
PHASE2This is a prospective single arm, phase II clinical trial to observe the ef...
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL: A Randomized, Open Phase II Trial
PHASE2This study is a randomized, open-label, multicenter, prospective clinical t...
Location
The First Affiliated Hospital of Nanchang University
A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP
PHASE2BTK participates in a variety of signal transduction of innate and adaptive...
Location
Multiple Locations